We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

Back to rankings

155 hedge funds and large institutions have $1.34B invested in NPS PHARMACEUTICALS INC in 2013 Q2 according to their latest regulatory filings, with 155 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more call options, than puts

Call options by funds: $9.72M | Put options by funds: $5.15M

Holders
155
Holders Change
+155
Holders Change %
–
% of All Funds
5.06%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
155
Increased
–
Reduced
–
Closed
–
Calls
$9.72M
Puts
$5.15M
Net Calls
+$4.57M
Net Calls Change
+$4.57M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
76
Bank of America
North Carolina
$1.38M +$1.26M +91,275 New
Swiss National Bank
77
Swiss National Bank
Switzerland
$1.37M +$1.25M +90,500 New
KCM
78
Kingdon Capital Management
New York
$1.34M +$1.23M +89,000 New
IG
79
ING Group
Netherlands
$1.26M +$1.16M +83,402 New
BIM
80
Bogle Investment Management
Massachusetts
$1.25M +$1.15M +82,967 New
AC
81
Amici Capital
New York
$1.21M +$1.11M +80,000 New
CS
82
Credit Suisse
Switzerland
$1.2M +$1.1M +79,522 New
ProShare Advisors
83
ProShare Advisors
Maryland
$1.2M +$1.1M +79,374 New
State Board of Administration of Florida Retirement System
84
State Board of Administration of Florida Retirement System
Florida
$1.2M +$1.1M +79,421 New
HI
85
HBK Investments
Texas
$1.16M +$1.07M +77,100 New
MLICM
86
Metropolitan Life Insurance Company (MetLife)
New York
$1.16M +$1.06M +76,599 New
RHJA
87
Rice Hall James & Associates
California
$1.14M +$1.05M +75,681 New
Balyasny Asset Management
88
Balyasny Asset Management
Illinois
$1.06M +$970K +70,000 New
WMSA
89
Weiss Multi-Strategy Advisers
New York
$1.06M +$970K +70,000 New
BG
90
BlackRock Group
United Kingdom
$1.03M +$949K +68,476 New
AIG
91
American International Group
New York
$1.01M +$929K +67,035 New
LMF
92
LMR Master Fund
Cayman Islands
$1.01M +$927K +66,944 New
EEG
93
E.E. Geduld
$918K +$842K +60,750 New
UOC
94
UBS O'Connor
Illinois
$912K +$837K +60,400 New
BA
95
BlackRock Advisors
Delaware
$893K +$818K +59,075 New
VOYA Investment Management
96
VOYA Investment Management
Georgia
$862K +$791K +57,104 New
KIA
97
Kopp Investment Advisors
Minnesota
$847K +$776K +56,045 New
TRSOTSOK
98
Teachers Retirement System of the State of Kentucky
Kentucky
$821K +$753K +54,315 New
CBOA
99
Commonwealth Bank of Australia
Australia
$811K +$744K +53,700 New
GCP
100
GSA Capital Partners
United Kingdom
$806K +$739K +53,329 New
2 3
4
5 6

NPSP Hedge Fund Activity: Q2 2013 in Review

155 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q2 2013, worth a combined $1.34B.

Buyers outnumbered sellers: 155 funds opened new NPSP positions and 0 closed out — a net gain of 155 holders — while 0 added to existing stakes and 0 trimmed.

  • 155 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.34B of NPS PHARMACEUTICALS INC stock for Q2 2013.
  • 155 funds opened new NPS PHARMACEUTICALS INC positions in Q2 2013 and 0 closed out, a net change of +155 holders.

Based on aggregated 13F filings for Q2 2013.